Pluristem Therapeutics Inc. is a bio-technology company that focuses on researching, developing and manufacturing cell therapeutic products for the treatment of various health conditions. The company is currently working on developing several placental expanded (PLX) based cell therapy products for the treatment of various conditions, including a Phase III clinical trial for the recovery after surgery for hip fracture. Pluristem also collaborates with other organizations on a project to evaluate the potential of PLX cell therapies in preventing and treating medical conditions caused during space missions.